Markus Manz

70PUBLICATIONS
300CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical mycologyCardiology (incl. cardiovascular diseases)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jul 13, 2026
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy.

|Jun 17, 2026
Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis.

|Jun 08, 2026
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies.

|May 28, 2026
CD117-targeted HCT preconditioning in AML and MDS.

|May 11, 2026
A Bispecific Anti-Fluorescein × Anti-CD3 T-cell Engager in Combination with Fluoresceinated Adaptors Enables Lysis of AML Cells.

|May 07, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosis.

Pageof 12

Frequent Collaborators

12 joint publications

Christian Pellegrino

9 joint publications

Francisco Caiado

9 joint publications

Bob Löwenberg

9 joint publications

Dario Neri